Friday - January 30, 2026
ctDNA Levels After Neoadjuvant Therapy May Predict Breast Cancer Recurrence Better Than Pathologic Complete Response
January 14, 2026
PHILADELPHIA, Pennsylvania, Jan. 14 [Category: Medical] -- The American Association for Cancer Research posted the following news release:

* * *

ctDNA Levels After Neoadjuvant Therapy May Predict Breast Cancer Recurrence Better Than Pathologic Complete Response

*

ctDNA status after neoadjuvant therapy may also inform adjuvant therapy

PHILADELPHIA - The presence of circulating tumor DNA (ctDNA) in patients with human epidermal grow . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products